comparemela.com

Latest Breaking News On - Runway growth - Page 17 : comparemela.com

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

Stefan norbomThomasb ratermanDavid sprengExchange commissionRunway growth capitalRunway growth finance corpInvestment companyGrowth financeRunway growth investor relationsInvestment company actPrivate securities litigation reform actRunway growthProsek partnersChief financial officerChief operating officer

Runway Growth Finance Corp Announces Date for Fourth Quarter and Full Year 2022 Financial Results and Conference Call

08.02.2023 - WOODSIDE, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) - Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today .

David sprengRunway growth capitalExchange commissionRunway growth finance corpInvestment companyInvestment company actPrivate securities litigation reform actRunway growth

SetPoint Medical Announces Expanded $65M Credit Facility to Support Development of the Company s Novel Platform for Rheumatoid Arthritis

SetPoint Medical Announces Expanded $65M Credit Facility to Support Development of the Company s Novel Platform for Rheumatoid Arthritis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAnnika parrishMurthyv simhambhatlaDavid sprengIgor dacruzExchange commissionRunway growth capitalRunway growth finance corpLife sciencesDrug administrationPoint medicalSetpoint medicalManaging directorRunway growthRunway growth financePrivate securities litigation reform act

SetPoint Medical raises $80M for nerve stimulation tech that treats autoimmune disease

Autoimmune disease treatment developer SetPoint Medical announced today that it raised $80 million in a preferred stock financing.

United statesMurthyv simhambhatlaZack scottTopspin fundEnterprise associatesRichard king mellon foundationBoston scientificCalifornia based setpoint medicalNorwest venture partnersViking global investorsGilmartin capitalNew enterprise associatesAction potential venture capitalEuclidean capitalMorgenthaler venturesShangbay capital

SetPoint Medical Raises $80M to Advance Platform for Autoimmune Diseases

SetPointMedical announced $80M in Series C equity and $65M led by new investors, Norwest Venture Partners and Viking Global Investors.

Should knowSetpoint medicalNorwest venture partnersViking global investorsRunway growth

vimarsana © 2020. All Rights Reserved.